Come up with a name for your new list and we'll add to it:
SYNTARGA B.V. was acquired by
Synthon on June 23, 2011.
Syntarga is a biopharmaceutical company creating chemistries to link anticancer activity to specificity. The company develops releasable linker technologies and potent linker-drug combinations for co…